Home › Research › Cognitive tests and assessment
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study
Kaufer DI, Cummings JL, Christine D.. Journal of geriatric psychiatry and neurology, 1996-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
We conducted an open-label study designed to assess the effects of tacrine on behavioral changes in patients with Alzheimer's disease (AD). Twenty-eight subjects completed a baseline evaluation and at least one assessment during treatment. Behavioral symptoms and cognitive function were assessed with the Neuropsychiatric Inventory (NPI) and Mini-Mental State Examination (MMSE), respectively.
What this study adds
Evidence grade: Low
This is a trial. In this open-label study, 28 patients with Alzheimer's disease received tacrine and their behavioral symptoms and cognition were assessed. The open-label design without a control group means these preliminary results cannot establish whether tacrine is an effective treatment.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kaufer, D. I., Cummings, J. L., & Christine, D. (1996). Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. Journal of geriatric psychiatry and neurology. https://doi.org/10.1177/089198879600900101
Vancouver
Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. Journal of geriatric psychiatry and neurology. 1996. doi:10.1177/089198879600900101. PMID: 8679057.
BibTeX
@article{kaufer1996-8679057,
author = {Kaufer, D. I. and Cummings, J. L. and Christine, D.},
title = {{Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study}},
journal = {Journal of geriatric psychiatry and neurology},
year = {1996},
doi = {10.1177/089198879600900101},
pmid = {8679057},
url = {https://doi.org/10.1177/089198879600900101}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Twenty-eight subjects completed a baseline evaluation and at least one assessment during treatment.
- Behavioral symptoms and cognitive function were assessed with the Neuropsychiatric Inventory (NPI) and Mini-Mental State Examination (MMSE), respectively.
- The mean NPI score at the maximum individual dose of tacrine attained was markedly decreased (behavior improved, compared to baseline).
- Symptoms of anxiety, apathy, hallucinations, aberrant motor behaviors, and disinhibition were most responsive.
Why it matters
In this open-label study, 28 patients with Alzheimer's disease received tacrine and their behavioral symptoms and cognition were assessed. The open-label design without a control group means these preliminary results cannot establish whether tacrine is an effective treatment.
Study details
- Study designopen-label trial
- Evidence strengthLow
How this study scored 42/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 40 of the 96 points we could judge it on, which is 42 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of geriatric psychiatry and neurology) |
| Journal's citation record | 1 / 4 | Journal of Geriatric Psychiatry and Neurology: journal h-index 105 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | Design recorded as “open-label trial”, which our rubric does not rank (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1996 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 210 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 6.6 citations a year over 32 year(s) since 1996 |
| Impact for its field and year | 4 / 6 | Cited 18.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 12 other studies in this library |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Dianne Christine holds only 5 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 2 / 3 | University of California, Los Angeles: institution h-index 1,923 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8679057) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 40 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 40 of the 96 points we could judge it on is 42 out of 100. |
| Total | 42 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
12 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Cognitive tests and assessment from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.